AASLD: American Association for the Study of Liver Diseases
Home | Contact Us
About Us | News | JoinPatients | AASLD Foundation | Special Interest Groups | Committees

Secretary 2013-2015 

Gary L. DavisGary L Davis, MD, FACP, FAASLD 

Dr. Gary L. Davis received his medical degree from the University of Minnesota, completed a residency in Internal Medicine and fellowship in Gastroenterology at the Mayo Clinic in Rochester, Minnesota, and obtained a fellowship in Hepatology at the National Institutes of Health in Bethesda, Maryland. He also trained in business and medical management at the University of Wisconsin and Southern Methodist University.  He was Professor of Medicine, Director of the Section of Hepatobiliary Diseases, and Medical Director of Liver Transplantation at the University of Florida College of Medicine from 1984 until 2002. He then moved to Baylor University Medical Center in Dallas, Texas as Director of Hepatology and Medical Director of Liver Transplantation. He retired from clinical medicine in 2013.

Dr. Davis' major areas of interest and experience are viral hepatitis, autoimmune hepatitis, liver cancer, and liver transplantation. He has also been heavily involved in healthcare and practice administration. He is certified by the American Board of Internal Medicine in Internal Medicine and Gastroenterology. Dr. Davis is a member of the American Association for the Study of Liver Diseases and has twice served as a member of its governing board. He has served in many other capacities for AASLD, United Network for Organ Sharing, American College of Transplantation, and other organizations. Dr. Davis has authored almost 300 peer-reviewed articles and reviews, including the chapters on hepatitis C in all of the major textbooks in gastroenterology and hepatology.

Currently, Dr. Davis is President of MedLogician Consulting, a healthcare planning and administration consulting firm. He serves as Secretary of the American Association for the Study of Liver Diseases and is a Co-chair for the AASLD/IDSA HCV Guidance writing group.